Loading...
Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy
BACKGROUND: Statins may reduce the risk of first and recurrent venous thromboembolism (VTE). No data are available on their potential benefit in patients treated with the oral anticoagulant rivaroxaban. METHODS: The EINSTEIN DVT/PE and EINSTEIN Extension studies compared rivaroxaban with standard of...
Na minha lista:
| Udgivet i: | Thromb J |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4334416/ https://ncbi.nlm.nih.gov/pubmed/25698905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-12-26 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|